Where To Look When You Claim Merger Efficiencies
For much of the past two decades, EU merger rules have focused…
Did the UK Court of Appeals Make Excessive Pricing Claims Easier?
In Pfizer/Flynn (Phenytoin II), the Court of Appeal closed one of UK…
Appeal Court Restores CMA Victory Over Pharma Pricing
The UK Court of Appeal has completely overturned a lower tribunal's intervention,…
Financial Literacy as a Litigation Strategy: Lessons from Apple and Google
Recent rulings from the UK’s Competition Appeal Tribunal (CAT) show that regulators…
Pfizer to Acquire Obesity Drug Developer Metsera for $10B, Winning Bidding War Against Denmark’s Novo Nordisk
Pfizer announced it has agreed to acquire the obesity drug developer Metsera…
Robust, but Incomplete: Inside the CMA’s Profitability Analysis of Google
When the UK’s Competition and Markets Authority confirmed Google’s Strategic Market Status…
Pfizer’s $25.5 Million Effexor XR Antitrust Settlement Marks Turning Point in Long-standing Legal Battle
The Effexor XR Antitrust Litigation, centered around allegations of collusion between pharmaceutical…